09:42 AM EDT, 03/21/2024 (MT Newswires) -- Marc Wilson, CFO, around March 18, 2024, sold 10,925 shares in Crinetics Pharmaceuticals ( CRNX ) for $449,793. Following the Form 4 filing with the SEC, Wilson has control over a total of 110,630 shares of the company, with 110,630 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000120919124005009/xslF345X03/doc4.xml

Price: 44.6, Change: -0.89, Percent Change: -1.96